EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells






Circulation Research 104(4): 531-540

ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells

Abnormal vascular smooth muscle cell (VSMC) contraction plays an important role in vascular diseases. The RhoA/ROCK signaling pathway is now well recognized to mediate vascular smooth muscle contraction in response to vasoconstrictors by inhibiting myosin phosphatase (MLCP) activity and increasing myosin light chain phosphorylation. Two ROCK isoforms, ROCK1 and ROCK2, are expressed in many tissues, yet the isoform-specific roles of ROCK1 and ROCK2 in vascular smooth muscle and the mechanism of ROCK-mediated regulation of MLCP are not well understood. In this study, ROCK2, but not ROCK1, bound directly to the myosin binding subunit of MLCP, yet both ROCK isoforms regulated MLCP and myosin light chain phosphorylation. Despite that both ROCK1 and ROCK2 regulated MLCP, the ROCK isoforms had distinct and opposing effects on VSMC morphology and ROCK2, but not ROCK1, had a predominant role in VSMC contractility. These data support that although the ROCK isoforms both regulate MLCP and myosin light chain phosphorylation through different mechanisms, they have distinct roles in VSMC function.


Accession: 055338121

PMID: 19131646

DOI: 10.1161/CIRCRESAHA.108.188524



Related references

Yoshioka, K.; Sugimoto, N.; Takuwa, N.; Takuwa, Y., 2007: Essential role for class II phosphoinositide 3-kinase alpha-isoform in Ca2+-induced, rho- and rho kinase-dependent regulation of myosin phosphatase and contraction in isolated vascular smooth muscle cells. The laser confocal fluorescent microscope-based observation of contractile responses in green fluorescent protein-expressing differentiated vascular smooth muscle cells, combined with the RNA interference-mediated gene-silencing technique, allowe...

Yoshioka, K.; Sugimoto, N.; Takuwa, N.; Takuwa, Y., 2006: Essential role for class II phosphoinositide 3-kinase alpha-isoform in Ca2+-induced, Rho- and Rho kinase-dependent regulation of myosin phosphatase and contraction in isolated vascular smooth muscle cells. The laser confocal fluorescent microscope-based observation of contractile responses in green fluorescent protein-expressing differentiated vascular smooth muscle cells, combined with the RNA interference-mediated gene-silencing technique, allowed...

Payne, M.C.; Zhang, H-Ying.; Prosdocimo, T.; Joyce, K.M.; Koga, Y.; Ikebe, M.; Fisher, S.A., 2005: Myosin phosphatase isoform switching in vascular smooth muscle development. We are using the myosin phosphatase targeting Subunit (MYPT1) its a model gene to study smooth muscle phenotypic diversity. Myosin phosphatase (MP) is the primary effector of smooth muscle relaxation, and MYPT1 is a key target of signals that regu...

Li, S.; Bao, J.; Oishi, K.; Uchida, M.K.; Kohama, K., 2002: Down-regulation of the short isoform of myosin light chain kinase inhibits migration of vascular smooth muscle cells. Molecular Biology of the Cell 13(Supplement): 38a, Nov

Wang, Yu; Yoshioka, Kazuaki; Azam, Mohammed-Ali; Takuwa, Noriko; Sakurada, Sotaro; Kayaba, Yuji; Sugimoto, Naotoshi; Inoki, Isao; Kimura, Takaharu; Kuwaki, Tomoyuki; Takuwa, Yoh, 2006: Class II phosphoinositide 3-kinase alpha-isoform regulates Rho, myosin phosphatase and contraction in vascular smooth muscle. We demonstrated previously that membrane depolarization and excitatory receptor agonists such as noradrenaline induce Ca2+- dependent Rho activation in VSM (vascular smooth muscle), resulting in MP (myosin phosphatase) inhibition through the mecha...

Wang, Y.; Yoshioka, K.; Azam, M.Ali.; Takuwa, N.; Sakurada, S.; Kayaba, Y.; Sugimoto, N.; Inoki, I.; Kimura, T.; Kuwaki, T.; Takuwa, Y., 2005: Class II phosphoinositide 3-kinase alpha-isoform regulates Rho, myosin phosphatase and contraction in vascular smooth muscle. We demonstrated previously that membrane depolarization and excitatory receptor agonists such as noradrenaline induce Ca2+-dependent Rho activation in VSM (vascular smooth muscle), resulting in MP (myosin phosphatase) inhibition through the mechan...

Giuriato L.; Scatena M.; Chiavegato A.; Scannapieco G.; Pauletto P.; Sartore S., 1991: Regulation of myosin isoform expression and cell heterogeneity in the vascular smooth muscle. European Journal of Cell Biology Supplement (35): 39

Kim, J.In.; Urban, M.; Young, G.D.; Eto, M., 2012: Reciprocal regulation controlling the expression of CPI-17, a specific inhibitor protein for the myosin light chain phosphatase in vascular smooth muscle cells. Cellular activity of the myosin light chain phosphatase (MLCP) determines agonist-induced force development of smooth muscle (SM). CPI-17 is an endogenous inhibitor protein for MLCP, responsible for mediating G-protein signaling into SM contractio...

Nagai R.; Kuro O.M.; Tsuchimochi H.; Yazaki Y.; Ohkubo A.; Takaku F., 1990: Developmental regulation of vascular smooth muscle myosin heavy chain isoform expression. Japanese Circulation Journal 54(7): 714

Kitazawa, T.; Eto, M.; Woodsome, T.P.; Brautigan, D.L., 2000: Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility. Myosin light chain phosphatase (MLCP) plays a pivotal role in smooth muscle contraction by regulating Ca(2+) sensitivity of myosin light chain phosphorylation. A smooth muscle phosphoprotein called CPI-17 specifically and potently inhibits MLCP in...